Floatz logo

IODINE I-131

Lymphoma

SWOG Cancer Research NetworkSmall moleculePhase 3Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
65/ 100

Competitive context

243 Active assets in the Lymphoma cohort.

Asset / SponsorPhaseRating
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
The Lymphoma Academic Research Organisation
Phase 4BBB
VINBLASTINE
Intensity Therapeutics, Inc.
Phase 4BBB
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
BLEOMYCIN
Shandong Provincial Hospital
Phase 4BB
PREDNISONE TABLETS
Beth Israel Deaconess Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

IODINE I-131 is also rated in:

Lymphoma, B-CellDormant
CCC
Indicative ·
54 / 100
View asset →
Multiple MyelomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →